Filter
2330
Filtered Results: 2330
Text search:
regimens
Featured
Recommendations
240
New Publications
604
Language
Document type
No document type
1456
Guidelines
356
Studies & Reports
283
Manuals
79
Fact sheets
49
Strategic & Response Plan
47
Training Material
25
Infographics
18
Situation Updates
9
Resource Platforms
4
Brochures
2
Online Courses
2
Countries / Regions
India
137
South Africa
72
Global
70
Kenya
56
Ethiopia
55
Tanzania
50
Western and Central Europe
43
Uganda
38
Zambia
37
Nigeria
36
Africa
35
Nepal
34
Malawi
31
Latin America and the Carribbean
31
Eastern Europe
31
Rwanda
29
Liberia
25
Ghana
24
Philippines
24
Ukraine
23
Bangladesh
20
Namibia
20
Indonesia
19
Zimbabwe
18
Myanmar / Burma
18
Cambodia
17
Asia
17
South–East Asia Region
16
Mozambique
14
Russia
14
Sierra Leone
13
Botswana
12
Lesotho
11
Senegal
10
West and Central Africa
10
Brazil
9
Colombia
9
East and Southern Africa
9
Eswatini/ Swaziland
8
Middle East and North Africa
8
Congo, Democratic Republic of
7
Cameroon
7
Germany
7
Syria
7
Thailand
7
Paraguay
6
Venezuela
6
Georgia
6
Haiti
5
Pakistan
5
Argentina
5
Western Pacific Region
5
Albania
5
Tajikistan
5
USA
4
South Sudan
4
Benin
4
Vietnam
4
Somalia
3
Afghanistan
3
China
3
Peru
3
Eastern Europe and Central Asia
3
Bhutan
3
Estonia
3
Jamaica
3
Guinea
2
Burkina Faso
2
Iraq
2
Jordan
2
Sudan
2
North Macedonia
2
Bolivia
2
Sri Lanka
2
Laos
2
Timor Leste/ East Timor
2
Romania
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Central African Republic
1
Serbia
1
El Salvador
1
Greece
1
Chile
1
Yemen
1
Other region
1
Fiji
1
Solomon Islands
1
North Korea
1
Armenia
1
Moldova
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
835
Clinical Guidelines
340
Public Health
108
Women & Child Health
101
Capacity Building
51
Key Resources
21
Pharmacy & Technologies
18
Toolboxes
HIV
412
TB
382
COVID-19
93
NTDs
87
AMR
79
Pharmacy
63
NCDs
60
Mental Health
54
Caregiver
43
Ebola
34
Refugee
27
Rapid Response
26
Conflict
19
Cholera
13
Polio
13
Disability
11
Planetary Health
10
Natural Hazards
7
Health Financing Toolbox
6
Specific Hazards
5
Global Health Education
4
Social Ethics
4
Zika
2
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
